RMTI Rockwell Medical Inc

Rockwell Medical Inc is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism, and hemodialysis.

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  03/05/2001
Outstanding shares:  93,966,381
Average volume:  2,365,518
Market cap:   $38,704,752
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    774374102
ISIN:        US7743741024
Valuation   (See tab for details)
PE ratio:   -1.11
PB ratio:   3.23
PS ratio:   0.63
Return on equity:   -214.00%
Net income %:   -38.44%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy